Nishat Shaikh is Vice President of Intellectual Property and Contracts at GentiBio. Nishat was previously at Novartis, where she led the global patent strategy for several of Novartis’s key CAR-T assets, including the first approved CAR-T product, and Novartis’s proprietary CAR-T cell and vector manufacturing platforms. Prior to Novartis, Nishat practiced in the law firm setting, where she counseled academic institutions, biotechs, and pharmaceutical companies regarding patent prosecution, freedom-to-operate analyses, litigation, and licensing. Nishat received her JD, cum laude, from Boston College Law School and her BS from Cornell University in Biological Sciences, concentration in Molecular and Cell Biology, cum laude with Distinction in Research. Prior to attending law school, Nishat was a bench scientist working in humanized antibody development at a San Diego biotech. Nishat lives in the Boston metro area and enjoys spending time with her family and friends, traveling, and reading. Her love of learning has turned her into a serial hobbyist. Her current interests include knitting, rock tumbling, and orchid collecting.
Nishat Shaikh, JD
VP, Intellectual Property & Contracts
